Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe Covid-19
David Berlin, Roy M. Gulick, Fernando J. Martínez
New England Journal of Medicine (2020) Vol. 383, Iss. 25, pp. 2451-2460
Closed Access | Times Cited: 1390

Showing 26-50 of 1390 citing articles:

COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experience
James B. Caress, Ryan Castoro, Zachary Simmons, et al.
Muscle & Nerve (2020) Vol. 62, Iss. 4, pp. 485-491
Open Access | Times Cited: 256
Local and systemic responses to SARS-CoV-2 infection in children and adults
Masahiro Yoshida, Kaylee B. Worlock, Ni Huang, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 321-327
Open Access | Times Cited: 248
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Abdul Aleem, Abdul Samad, Amy Slenker
(2021) Vol. 01, pp. 01-01
Closed Access | Times Cited: 242
Monocytes and Macrophages in COVID-19
Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 235
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
Anna C. Aschenbrenner, Maria Mouktaroudi, Benjamin Krämer, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 233
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19
Hidde Heesakkers, Johannes G. van der Hoeven, Stijn Corsten, et al.
JAMA (2022) Vol. 327, Iss. 6, pp. 559-559
Open Access | Times Cited: 233
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial
Stéphan Ehrmann, Jie Li, Miguel Ibarra‐Estrada, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1387-1395
Open Access | Times Cited: 206
Vitamin D, infections and immunity
Aiten Ismailova, John H. White
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 23, Iss. 2, pp. 265-277
Open Access | Times Cited: 205
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Monique G.P. van der Wijst, Sara E. Vazquez, George C. Hartoularos, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 612
Open Access | Times Cited: 196
Macrophage Polarity and Disease Control
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 144-144
Open Access | Times Cited: 195
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 191
Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis
Enrico Ammirati, L Lupi, Matteo Palazzini, et al.
Circulation (2022) Vol. 145, Iss. 15, pp. 1123-1139
Open Access | Times Cited: 184
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
Oliver J. McElvaney, Gerard F. Curley, Stefan Rose‐John, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 643-654
Open Access | Times Cited: 181
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Florence A. Aeschlimann, Nassim Ait-Abdallah, Jean-David Albert, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 4, pp. 527-538
Open Access | Times Cited: 177
Animal and translational models of SARS-CoV-2 infection and COVID-19
Matt D. Johansen, Aaron T. Irving, Xavier Montagutelli, et al.
Mucosal Immunology (2020) Vol. 13, Iss. 6, pp. 877-891
Open Access | Times Cited: 176
Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses
Yaniv Lustig, Shlomit Keler, Rachel Kolodny, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e2444-e2449
Open Access | Times Cited: 167
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
Chunlong Ma, M. Sacco, Zilei Xia, et al.
ACS Central Science (2021) Vol. 7, Iss. 7, pp. 1245-1260
Open Access | Times Cited: 158
A single-cell transcriptomic landscape of the lungs of patients with COVID-19
Si Wang, Xiaohong Yao, Shuai Ma, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 12, pp. 1314-1328
Open Access | Times Cited: 158
Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Kevin Cares-Marambio, Yessenia Montenegro-Jiménez, Rodrigo Torres‐Castro, et al.
Chronic Respiratory Disease (2021) Vol. 18
Open Access | Times Cited: 157
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19
Roberto Caricchio, Antonio Abbate, И. Г. Гордеев, et al.
JAMA (2021) Vol. 326, Iss. 3, pp. 230-230
Open Access | Times Cited: 157
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
Woon H. Chong, Biplab K. Saha, Ananthakrishnan Ramani, et al.
Infection (2021) Vol. 49, Iss. 4, pp. 591-605
Open Access | Times Cited: 155
Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19
Avraham Unterman, Tomokazu S. Sumida, Nima Nouri, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 154
COVID-19: Complement, Coagulation, and Collateral Damage
Martin W. Lo, Claudia Kemper, Trent M. Woodruff
The Journal of Immunology (2020) Vol. 205, Iss. 6, pp. 1488-1495
Open Access | Times Cited: 151
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
François‐Xavier Danlos, Claudia Grajeda‐Iglesias, Sylvère Durand, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 145
Postintensive Care Syndrome in Survivors of Critical Illness Related to Coronavirus Disease 2019: Cohort Study From a New York City Critical Care Recovery Clinic*
Miguel Martillo, Neha Dangayach, Laura Tabacof, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 9, pp. 1427-1438
Open Access | Times Cited: 135

Scroll to top